IVF Success Rates: What the Clinical Evidence Actually Tells You
25 August 2026 · 6 min read · kolkata
When you search for IVF success rates in Kolkata, the numbers you find can range wildly — and that range is not accidental. Understanding what the data actually measures, and what drives outcomes up or down, is the most useful thing you can do before you begin treatment. This evidence-led guide unpacks exactly that, in plain language.
Why the Number You See Online Is Rarely the Number That Applies to You
Most websites headline a single IVF success rate — say, "55% success" — without explaining what that figure is measuring. Is it a positive pregnancy test? A heartbeat on ultrasound? A baby actually born at home? These are four different events with four different probabilities, and conflating them is one of the most common sources of confusion couples in Kolkata encounter when they start researching fertility treatment.
The metric that matters most, clinically and personally, is the live birth rate (LBR) — the percentage of initiated IVF cycles that result in a live-born baby. It is consistently lower than the clinical pregnancy rate (which counts a gestational sac on ultrasound) and far lower than the biochemical pregnancy rate (a positive blood test). When you are comparing clinics or reading published studies, always ask: which endpoint is being reported?
What Peer-Reviewed Data Says About IVF Outcomes
Age Is the Single Strongest Predictor
Across multiple large registries — including data published by the Society for Assisted Reproductive Technology (SART) and the Human Fertilisation and Embryology Authority (HFEA) — maternal age at the time of egg retrieval consistently emerges as the dominant variable in IVF success.
Approximate live birth rates per embryo transfer by age bracket (based on published registry data):
- Under 35: 40–50% per transfer cycle
- 35–37: 30–40% per transfer cycle
- 38–40: 20–30% per transfer cycle
- 41–42: 10–18% per transfer cycle
- Over 42: typically below 10% with own eggs
These figures are population averages. Your individual result will depend on a cluster of additional factors discussed below. They are shared here to set realistic expectations, not to close doors.
Ovarian Reserve: AMH, AFC, and What They Predict
Anti-Müllerian hormone (AMH) and antral follicle count (AFC) — both measurable through a blood test and ultrasound scan — give your fertility specialist a window into how many eggs your ovaries are likely to produce in a stimulation cycle. Low AMH does not make IVF impossible; it does affect the number of embryos available for selection and therefore the cumulative probability of success across multiple cycles.
A 2022 meta-analysis in Human Reproduction Update found that while AMH strongly predicts ovarian response, it is a weaker predictor of live birth rate once embryos are obtained — meaning egg quality (heavily linked to age) matters more than egg quantity at the point of transfer.
Embryo Quality and Chromosomal Testing
Not every fertilised egg develops into a chromosomally normal (euploid) embryo. The proportion of euploid embryos per retrieval cycle declines sharply with age — this is the biological basis of the age-effect described above.
Preimplantation Genetic Testing for Aneuploidies (PGT-A) allows laboratories to screen embryos before transfer. Evidence on PGT-A is nuanced: in women under 35 with good ovarian reserve, the benefit is debated; in women over 37 or those with recurrent implantation failure, multiple studies show it meaningfully improves the per-transfer live birth rate by reducing transfers of chromosomally abnormal embryos.
Male Factor and Its Measurable Impact
Severe male factor infertility — very low sperm count, motility, or morphology — is addressed through Intracytoplasmic Sperm Injection (ICSI), where a single sperm is injected directly into the egg. Landmark RCT data and routine ICSI practice data show fertilisation rates of 70–80% with ICSI in male factor cases, comparable to standard IVF fertilisation rates in couples without male factor. ICSI does not, however, fully compensate for underlying sperm DNA fragmentation — a point clinicians increasingly screen for.
Cumulative Success Rate: Why One Cycle Is Not the Full Story
Single-cycle live birth rates can feel discouraging. The clinically more meaningful figure is the cumulative live birth rate — the probability of a live birth after multiple transfers from one egg retrieval, or after multiple complete IVF cycles.
A large UK cohort study (Malizia et al., updated with HFEA data) showed cumulative live birth rates exceeding 65–70% after three complete IVF cycles in women under 40. This is why fertility specialists recommend patients think in terms of a treatment pathway rather than a single attempt, wherever physically and financially feasible.
How Clinics in India Measure and Report Outcomes
In India, IVF outcomes are not yet reported to a single national public registry in the way SART operates in the United States or HFEA in the UK. This means clinic-quoted figures vary in methodology and are difficult to verify independently. When you consult any fertility centre — including Abha Surgy Centre in Kolkata — it is entirely reasonable to ask:
- Is the quoted rate per cycle started, per egg retrieval, or per embryo transfer?
- Does it reflect clinical pregnancy or live birth?
- What is the clinic's policy on transferring multiple embryos, and how does that affect their headline number?
- What proportion of their patients fall into your age and diagnosis group?
These questions are not confrontational — any evidence-based programme will welcome them.
Factors Within Your Control That Evidence Supports
While age and ovarian reserve are not modifiable, a body of evidence points to several variables you can influence:
- BMI: Both underweight and obesity are associated with lower IVF success rates in published studies. A BMI in the 18.5–25 range is associated with better stimulation response and implantation rates.
- Smoking: Active smoking is consistently linked to lower fertilisation rates and higher miscarriage risk in IVF cohorts. Cessation before a cycle is evidence-backed advice.
- Uterine factors: Submucosal fibroids, endometrial polyps, and untreated hydrosalpinx have Level-1 evidence supporting their removal or treatment prior to IVF to improve implantation rates.
- Endometrial preparation: In frozen embryo transfer cycles, the protocol used to prepare the uterine lining (natural versus hormone-replacement-therapy cycle) is an active area of research, with no single protocol universally superior — your protocol should be individualised.
What the Data Does Not — and Cannot — Promise
Even in the most favourable demographic group, IVF does not guarantee a baby. The evidence shows probabilities, not certainties. A 45% live birth rate means 55 out of every 100 similar patients in that cycle will not bring a baby home from that attempt. Naming this plainly is not pessimism — it is the foundation of informed consent.
Couples in Kolkata navigating IVF often ask us whether a failed cycle means something was done wrong. In the majority of cases, the answer is no: early embryo loss is biologically common, and many failed transfers are chromosomally driven events that no intervention could have prevented.
Making Sense of Your Own Data
The most evidence-grounded step you can take right now is a structured fertility assessment — AMH, AFC, semen analysis, uterine evaluation — before deciding on a protocol. These results, interpreted by a specialist, convert population-level statistics into a picture that is specific to you.
At Abha Surgy Centre, our fertility team uses this baseline data to set individualised expectations and design stimulation protocols accordingly — because a number from a global registry is only the starting point, not your answer.
This article is for informational purposes only and does not constitute medical advice. Please consult a qualified fertility specialist before making any treatment decisions.
If you are considering IVF or want to understand your fertility profile in detail, we warmly invite you to book a consultation with Abha Surgy Centre's specialists in Kolkata — no pressure, just clarity.
Frequently asked questions
What is the difference between clinical pregnancy rate and live birth rate in IVF?
Clinical pregnancy rate counts cycles where an ultrasound confirms a gestational sac — typically around six weeks. Live birth rate counts only cycles where a baby is actually born alive. Live birth rate is the more meaningful metric for patients because clinical pregnancies can still end in miscarriage. Always ask clinics which figure they are quoting.
How much does IVF success rate drop after 35 in India?
Based on published international registry data, live birth rates per transfer drop from roughly 40–50% for women under 35 to around 30–40% at 35–37, and continue declining through the early 40s. Indian-specific registry data is not yet publicly consolidated, but the biological trend is consistent globally. Age at egg retrieval is the dominant factor.
Does a low AMH mean IVF will not work?
Not necessarily. Low AMH predicts a lower ovarian response — fewer eggs retrieved — but once embryos are obtained, AMH is a weaker predictor of whether a transfer will result in a live birth. Some women with low AMH conceive with IVF; your specialist will design a stimulation protocol to maximise your response safely.
Is ICSI better than standard IVF for all couples?
No. ICSI is specifically indicated for male factor infertility — low sperm count, motility, or morphology — and certain other indications like previous fertilisation failure. For couples without male factor, randomised trial data shows no consistent advantage of ICSI over conventional IVF. Your protocol should match your diagnosis.
How many IVF cycles should we try before stopping?
Evidence from large cohort studies suggests cumulative live birth rates improve meaningfully up to three to four complete IVF cycles, particularly in women under 40. Beyond that point, the marginal gain per additional cycle decreases. Your doctor should review your specific situation — including embryo quality data from previous cycles — before advising on further attempts.
Can lifestyle changes genuinely improve IVF success rates?
Yes, within limits. Achieving a healthy BMI, stopping smoking, moderating alcohol, and treating conditions like thyroid dysfunction or vitamin D deficiency are all supported by published evidence as beneficial before an IVF cycle. These changes improve the biological environment for stimulation and implantation, though they cannot override the primary effect of age and embryo quality.
Are IVF success rates at Indian clinics comparable to international figures?
India does not yet have a single mandatory public registry, so direct comparisons are difficult. Many Indian clinics with experienced embryology teams and modern laboratory infrastructure report outcomes in a similar range to international figures for comparable patient groups. When consulting any clinic in Kolkata or elsewhere, ask specifically for live birth rate data segmented by age group.